PT - JOURNAL ARTICLE AU - Czuppon, Peter AU - Schertzer, Emmanuel AU - Blanquart, François AU - Débarre, Florence TI - The stochastic dynamics of early epidemics: probability of establishment, initial growth rate, and infection cluster size at first detection AID - 10.1101/2020.11.17.20233403 DP - 2021 Jan 01 TA - medRxiv PG - 2020.11.17.20233403 4099 - http://medrxiv.org/content/early/2021/09/17/2020.11.17.20233403.short 4100 - http://medrxiv.org/content/early/2021/09/17/2020.11.17.20233403.full AB - Emerging epidemics and local infection clusters are initially prone to stochastic effects that can substantially impact the epidemic trajectory. While numerous studies are devoted to the deterministic regime of an established epidemic, mathematical descriptions of the initial phase of epidemic growth are comparatively rarer. Here, we review existing mathematical results on the epidemic size over time, and derive new results to elucidate the early dynamics of an infection cluster started by a single infected individual. We show that the initial growth of epidemics that eventually take off is accelerated by stochasticity. These results are critical to improve early cluster detection and control. As an application, we compute the distribution of the first detection time of an infected individual in an infection cluster depending on the testing effort, and estimate that the SARS-CoV-2 variant of concern Alpha detected in September 2020 first appeared in the United Kingdom early August 2020. We also compute a minimal testing frequency to detect clusters before they exceed a given threshold size. These results improve our theoretical understanding of early epidemics and will be useful for the study and control of local infectious disease clusters.Competing Interest StatementThe authors have declared no competing interest.Funding StatementEuropean Union's Horizon 2020 research and innovation program; Agence Nationale de la Recherche; CNRS Momentum grantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB/oversight body approval needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSource codes for the generated data is available on gitlab (see url in the manuscript).